Metsera Announces Positive Topline Phase 2a Clinical Data for Its Ultra-Long Acting GLP-1 Receptor Agonist, Met-097I
Metsera宣布其超长效GLP-1受体激动剂Met-097I的积极二期临床数据
Metsera Announces Positive Topline Phase 2a Clinical Data for Its Ultra-Long Acting GLP-1 Receptor Agonist, Met-097I
Metsera宣布其超长效GLP-1受体激动剂Met-097I的积极二期临床数据
使用浏览器的分享功能,分享给你的好友吧